Granules India arm gets 2 observations from USFDA
Granules India's US subsidiary has received two observations from the US health regulator following the completion of inspection.Granules Pharmaceuti29-10-2018
29-10-2018
Granules Pharmaceuticals Inc. Completed U.S. FDA Inspection
Granules Pharmaceuticals Inc. Completed U.S. FDA inspection29-10-2018
Intimation Of Schedule Of Earning Conference Call For Q2, FY 2018-19
Intimation of Schedule of Earning Conference Call for Q2, FY 2018-1923-10-2018
Intimation Of Date Of Board Meeting To Consider The Payment Of Second Interim Dividend For The FY 2018-19.
The Schedule of Board meeting to consider inter-alia, the un-audited financial results for the second quarter of the FY 2018-19 and to consider the payment of second interim dividend for the FY 2018-19 if any, was submitted vide application number 392027.22-10-2018
Board to consider Second Interim Dividend
Granules India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on October 29, 2018, inter alia, to consider and approve the Un-audited Financial Results for the second quarter ended September 30, 2018 and the payment of second interim dividend for the FY 2018-19, if any.Further, the Company has informed that Insider Trading Window of Granules India Limited is closed from October 22, 2018...22-10-2018
Board Meeting Intimation for Intimation Of Board Meeting
GRANULES INDIA LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2018 ,inter alia, to consider and approve Un-audited Financial Results for the Second Quarter ended September 30, 2018.22-10-2018
Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Of Regulations, 2015.
Submission of Certificate under regulation 40(9) of SEBI (LODR) of Regulations, 2015.16-10-2018
Compliance Certificate Under Regulation 7(3) Of SEBI (LISTING Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate under Regulation 7(3) of SEBI (LISTING Obligations and disclosure requirements) Regulations, 201512-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 017170 Name of the Signatory :- Chaitanya TummalaDesignation :- Company Secretary and Compliance Officer12-10-2018
Shareholding for the Period Ended September 30, 2018
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here10-10-2018